You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood conditions

Donidalorsen for preventing recurrent attacks of hereditary angioedema in people 12 years and over [ID6457]

  • In development
  • Reference number: GID-TA11576
  • Expected publication date:  18 June 2026
  • Project information
  • Project documents
  • Consultation

On this page

  1. Draft guidance: 1
  2. Invitation to participate
  3. Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6457
  4. Referral
  5. Topic selection

Documents

Documents created during the development process.

Draft guidance: 1

  • Draft guidance: 1

  • Draft guidance (downloadable version) (PDF 308 KB)

    Published:
    29 April 2026
  • Draft guidance (online commenting)

  • Committee papers (PDF 8.43 MB)

    Published:
    29 April 2026
  • Public committee slides (PDF 886 KB)

    Published:
    29 April 2026
  • Equality impact assessment (downloadable version) (PDF 140 KB)

    Published:
    29 April 2026

Invitation to participate

  • Final scope (PDF 147 KB)

    Published:
    28 August 2025
  • Final stakeholder list (PDF 152 KB)

    Published:
    28 August 2025
  • NICE's response to comments on the draft scope and provisional stakeholder list (PDF 350 KB)

    Published:
    28 August 2025
  • Equality impact assessment (scoping) (PDF 120 KB)

    Published:
    28 August 2025

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6457

  • Draft matrix post referral (PDF 100 KB)

    Published:
    02 May 2025
  • Draft scope post referral (PDF 102 KB)

    Published:
    02 May 2025

Referral

  • Referral

Topic selection

  • Topic selection

Back to top